Azenta Inc Q1 2026 Earnings Call: Strategic Focus, Financial Strength Amid Challenges

Azenta Inc (AZTA) reported strong growth in biorepositories and next-gen sequencing, with sustained customer demand and solid execution. Despite organic revenue declining 1% YoY and gross margin declining 360 basis points, the company has a $250 million share repurchase authorization and $571 million in cash for strategic capital deployment. It's making progress on operational excellence initiatives to drive margin expansion and expects to resolve quality issues in automated stores by Q2.